Literature DB >> 15131588

The different apoptotic potential of the p53 codon 72 alleles increases with age and modulates in vivo ischaemia-induced cell death.

M Bonafé1, S Salvioli, C Barbi, C Trapassi, F Tocco, G Storci, L Invidia, I Vannini, M Rossi, E Marzi, M Mishto, M Capri, F Olivieri, R Antonicelli, M Memo, D Uberti, B Nacmias, S Sorbi, D Monti, C Franceschi.   

Abstract

A common arginine to proline polymorphism is harboured at codon 72 of the human p53 gene. In this investigation, we found that fibroblasts and lymphocytes isolated from arginine allele homozygote centenarians and sexagenarians (Arg+) undergo an oxidative-stress-induced apoptosis at a higher extent than cells obtained from proline allele carriers (Pro+). At variance, the difference in apoptosis susceptibility between Arg+ and Pro+ is not significant when cells from 30-year-old people are studied. Further, we found that Arg+ and Pro+ cells from centenarians differ in the constitutive levels of p53 protein and p53/MDM2 complex, as well as in the levels of oxidative stress-induced p53/Bcl-xL complex and mitochondria-localised p53. Consistently, all these differences are less evident in cells from 30-year-old people. Finally, we investigated the in vivo functional relevance of the p53 codon 72 genotype in a group of old patients (66-99 years of age) affected by acute myocardial ischaemia, a clinical condition in which in vivo cell death occurs. We found that Arg+ patients show increased levels of Troponin I and CK-MB, two serum markers that correlate with the extent of the ischaemic damage in comparison to Pro+ patients. In conclusion, these data suggest that p53 codon 72 polymorphism contributes to a genetically determined variability in apoptotic susceptibility among old people, which has a potentially relevant role in the context of an age-related pathologic condition, such as myocardial ischaemia.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15131588     DOI: 10.1038/sj.cdd.4401415

Source DB:  PubMed          Journal:  Cell Death Differ        ISSN: 1350-9047            Impact factor:   15.828


  22 in total

1.  Functional analysis of the p53 codon 72 polymorphism in black South Africans with rheumatoid arthritis--a pilot study.

Authors:  Devapregasan Moodley; Girish M Mody; Anil A Chuturgoon
Journal:  Clin Rheumatol       Date:  2010-06-10       Impact factor: 2.980

2.  Genetic polymorphisms of TP53 and FAS promoter modulate the progression of coronary artery disease after coronary artery bypass grafting: a gender-specific view.

Authors:  A Beiras-Fernandez; M K Angele; C Koutang; P Lohse; B Reichart; P Lohse; S Eifert
Journal:  Inflamm Res       Date:  2011-02-01       Impact factor: 4.575

3.  Relationship between the Arg72Pro polymorphism of p53 and outcome for patients with traumatic brain injury.

Authors:  Pascual Martínez-Lucas; Jerónimo Moreno-Cuesta; Dolores C García-Olmo; Francisco Sánchez-Sánchez; Julio Escribano-Martínez; Ana Cuartero del Pozo; Máxima Lizán-García; Damián García-Olmo
Journal:  Intensive Care Med       Date:  2005-07-09       Impact factor: 17.440

4.  Codon 72 polymorphism (rs1042522) of TP53 is associated with changes in diastolic blood pressure over time.

Authors:  Erwin Reiling; Valeriya Lyssenko; Jolanda M A Boer; Sandra Imholz; W Monique M Verschuren; Bo Isomaa; Tiinamaija Tuomi; Leif Groop; Martijn E T Dollé
Journal:  Eur J Hum Genet       Date:  2011-12-21       Impact factor: 4.246

5.  p53 binding prevents phosphatase-mediated inactivation of diphosphorylated c-Jun N-terminal kinase.

Authors:  Pramod S Gowda; Fuchun Zhou; Linda V Chadwell; Donald G McEwen
Journal:  J Biol Chem       Date:  2012-03-30       Impact factor: 5.157

Review 6.  Genetic determinants of neuronal vulnerability to apoptosis.

Authors:  Angeles Almeida
Journal:  Cell Mol Life Sci       Date:  2012-06-14       Impact factor: 9.261

Review 7.  Gene polymorphisms, apoptotic capacity and cancer risk.

Authors:  Evgeny N Imyanitov
Journal:  Hum Genet       Date:  2009-02-12       Impact factor: 4.132

Review 8.  Genetic Modifiers of the p53 Pathway.

Authors:  Subhasree Basu; Maureen E Murphy
Journal:  Cold Spring Harb Perspect Med       Date:  2016-04-01       Impact factor: 6.915

Review 9.  "P53 codon 72 single base substitution in viral hepatitis C and hepatocarcinoma incidences".

Authors:  Emad F Eskander; Ahmed A Abd-Rabou; Shaymaa M M Yahya; Ashraf El Sherbini; Mervat S Mohamed; Olfat G Shaker
Journal:  Indian J Clin Biochem       Date:  2013-04-04

10.  TP53 codon 72 Gene Polymorphism Paradox in Associated with Various Carcinoma Incidences, Invasiveness and Chemotherapy Responses.

Authors:  Hung-Yu Lin; Chun-Hsiung Huang; Wen-Jen Wu; Li-Ching Chang; For-Wey Lung
Journal:  Int J Biomed Sci       Date:  2008-12
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.